104
Views
9
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLE

Role of inflammatory cells and adenosine in lung ischemia reoxygenation injury using a model of lung donation after cardiac death

, , , , , & show all
Pages 131-141 | Received 06 Sep 2015, Accepted 23 Feb 2016, Published online: 19 Apr 2016

References

  • Christie JD, Edwards LB, Kucheryavaya AY, Benden C, Dipchand AI, Dobbels F, et al. International Society of H, Lung T. The registry of the international society for heart and lung transplantation: 29th adult lung and heart-lung transplant report-2012. J Heart Lung Transpl. 2012;31:1073–1086.
  • De Vleeschauwer S, Van Raemdonck D, Vanaudenaerde B, Vos R, Meers C, Wauters S, et al. Early outcome after lung transplantation from non-heart-beating donors is comparable to heart-beating donors. J Heart Lung Transpl. 2009;28:380–387.
  • Burton CM, Carlsen J, Mortensen J, Andersen CB, Milman N, Iversen M. Long-term survival after lung transplantation depends on development and severity of bronchiolitis obliterans syndrome. J Heart Lung Transpl. 2007;26:681–686.
  • de Perrot M, Liu M, Waddell TK, Keshavjee S. Ischemia-reperfusion-induced lung injury. Am J of Resp. Crit. Care Med. 2003;167:490–511.
  • Fiser SM, Tribble CG, Long SM, Kaza AK, Cope JT, Laubach VE, et al. Lung transplant reperfusion injury involves pulmonary macrophages and circulating leukocytes in a biphasic response. J Thorac Cardiovasc Surg 2001;121:1069–1075.
  • de Perrot M, Young K, Imai Y, Liu M, Waddell TK, Fischer S, Zhang L, Keshavjee S. Recipient t cells mediate reperfusion injury after lung transplantation in the rat. J Immunol 2003;171:4995–5002.
  • Fernandez LG, Sharma AK, LaPar DJ, Kron IL, Laubach VE. Adenosine a1 receptor activation attenuates lung ischemia-reperfusion injury. J Thorac Cardiovasc Surg 2013;145:1654–1659.
  • Bion A, Fal M, Gouriou F, Le Prieur E, Dionnet F, Morin JP. Biphasic culture of rat lung slices for pharmacotoxicological evaluation of complex atmospheres. Cell Biol Toxicol 2002;18:301–314.
  • Morin JP, Baste JM, Gay A, Crochemore C, Corbiere C, Monteil C. Precision cut lung slices as an efficient tool for in vitro lung physio-pharmacotoxicology studies. Xenobiotica 2013;43:63–72.
  • Sroka J, Kordecka A, Wlosiak P, Madeja Z, Korohoda W. Separation methods for isolation of human polymorphonuclear leukocytes affect their motile activity. Eur J Cell Biol 2009;88:531–539.
  • Liberati TA, Randle MR, Toth LA. In vitro lung slices: A powerful approach for assessment of lung pathophysiology. Expert Review of Molecular Diagnostics 2010;10:501–508.
  • Sewald K, Braun A. Assessment of immunotoxicity using precision-cut tissue slices. Xenobiotica. 2013;43:84–97.
  • Bull DA, Connors RC, Reid BB, Albanil A, Stringham JC, Karwande SV. Improved biochemical preservation of lung slices during cold storage. J. Surgical Res. 2000;90:144–148.
  • Henjakovic M, Sewald K, Switalla S, Kaiser D, Muller M, Veres TZ, et al. Ex vivo testing of immune responses in precision-cut lung slices. Toxicol. Appl. Pharmaco. 2008;231:68–76.
  • Henjakovic M, Martin C, Hoymann HG, Sewald K, Ressmeyer AR, Dassow C, et al. Ex vivo lung function measurements in precision-cut lung slices (pcls) from chemical allergen-sensitized mice represent a suitable alternative to in vivo studies. Toxicol. Sci, 2008;106:444–453.
  • Switalla S, Lauenstein L, Prenzler F, Knothe S, Forster C, Fieguth HG, et al. Natural innate cytokine response to immunomodulators and adjuvants in human precision-cut lung slices. Toxicol. Appl. Pharmacol. 2010.
  • Ross SD, Tribble CG, Gaughen JR, Shockey KS, Parrino PE, Kron IL. Reduced neutrophil infiltration protects against lung reperfusion injury after transplantation. Ann. Thorac. Surg. 1999;67:1428–1433; discussion 1434.
  • Eppinger MJ, Deeb GM, Bolling SF, Ward PA. Mediators of ischemia-reperfusion injury of rat lung. Am. J. Pathol. 1997;150:1773–1784.
  • Steimle CN, Guynn TP, Morganroth ML, Bolling SF, Carr K, Deeb GM. Neutrophils are not necessary for ischemia-reperfusion lung injury. Ann. Thoracic Surg. 1992;53:64–72; discussion 72–63.
  • Zhao M, Fernandez LG, Doctor A, Sharma AK, Zarbock A, Tribble CG, et al. Alveolar macrophage activation is a key initiation signal for acute lung ischemia-reperfusion injury. Am. J. Physiol. Lung Cell. Mol. Physiol. 2006;291:L1018–L1026.
  • Maxey TS, Enelow RI, Gaston B, Kron IL, Laubach VE, Doctor A. Tumor necrosis factor-alpha from resident lung cells is a key initiating factor in pulmonary ischemia-reperfusion injury. J. Thorac. Cardiovasc. Surg. 2004;127:541–547.
  • Geudens N, Vanaudenaerde BM, Neyrinck AP, Van De Wauwer C, Vos R, Verleden GM, et al. The importance of lymphocytes in lung ischemia-reperfusion injury. Transplant. Proc. 2007;39:2659–2662.
  • Zaouali MA, Ben Abdennebi H, Padrissa-Altes S, Mahfoudh-Boussaid A, Rosello-Catafau J. Pharmacological strategies against cold ischemia reperfusion injury. Expert Opin. Phar. 2010;11:537–555.
  • Grenz A, Homann D, Eltzschig HK. Extracellular adenosine: A safety signal that dampens hypoxia-induced inflammation during ischemia. Antioxidants & Redox Signaling 2011;15:2221–2234.
  • Reece TB, Ellman PI, Maxey TS, Crosby IK, Warren PS, Chong TW, et al. Adenosine a2a receptor activation reduces inflammation and preserves pulmonary function in an in vivo model of lung transplantation. J. Thorac. Cardiovasc. Surg. 2005;129:1137–1143.
  • Sharma AK, Linden J, Kron IL, Laubach VE. Protection from pulmonary ischemia-reperfusion injury by adenosine a2a receptor activation. Resp. Res. 2009;10:58.
  • Sharma AK, Laubach VE, Ramos SI, Zhao Y, Stukenborg G, Linden J, et al. Adenosine a2a receptor activation on cd4+ t lymphocytes and neutrophils attenuates lung ischemia-reperfusion injury. J. Thorac. Cardiovasc. Surg. 2010;139:474–482.
  • Gazoni LM, Laubach VE, Mulloy DP, Bellizzi A, Unger EB, Linden J, et al. Additive protection against lung ischemia-reperfusion injury by adenosine a2a receptor activation before procurement and during reperfusion. J. Thorac. Cardiovasc. Surg. 2008;135:156–165.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.